AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

NCT01129193 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Amir Mortazavi

Collaborators